Encellin fetches $5.9m seed
Encellin, a personalized regenerative medicine biotech company, has secured $5.9 million in seed financing.
Encellin, a personalized regenerative medicine biotech company, has secured $5.9 million in seed financing.
Copyright PEI Media
Not for publication, email or dissemination